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ABSTRACT
Background and aims Tobacco use may be a risk factor for suicide mortality; however, prior research has produced
equivocal findings and has been limited by relatively small sample sizes to study the rare event of suicide, as well as a
lack of adjustment for other important factors, including psychiatric illness. We estimate the predictive association
between tobacco use disorder and the risk of suicide mortality, adjusting for other important variables. Design A
prospective cohort study. Setting The United States Veterans Health Administration (VHA). Participants All indi-
viduals who received VHA services in fiscal year (FY) 2005 and were alive at the start of FY 2006 (n = 4 863 086).
Measurements Tobacco use disorder was assessed via FYs 2004–05 VHA National Patient Care Database records.
The outcome of suicide mortality was assessed during the follow-up interval from the beginning of FY 2006 to the end
of FY 2008 using National Death Index records. Findings Of the 4 863 086 individuals in the study, 4823 died
by suicide during the follow-up interval. In the unadjusted model, tobacco use disorder was associated with an
increased risk of suicide [hazard ratio (HR) = 1.88; 95% confidence interval (CI) = 1.76, 2.02]. After adjustment for
model covariates, the association remained statistically significant, although attenuated (HR = 1.36, 95% CI = 1.27,
1.46). Conclusions Tobacco use disorder may confer a modest excess risk of death by suicide. Psychiatric disorders
may partially explain the relationship between tobacco use disorder and suicide.
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INTRODUCTION
Suicide is one of the leading causes of death and years of
potential life lost in the world. Globally, an estimated 1
million people die by suicide every year [1]. In the United
States, suicide ranks among the 10 leading causes of
death [2]. In 2009, for example, more than 36 000 indi-
viduals died by suicide in the United States [2].
Previous epidemiological studies have linked tobacco
use and tobacco use disorder (TUD)with an increased risk
of suicidal behavior [3–5]. For example, Breslau and col-
leagues found that daily cigarette smoking predicted sub-
sequent suicidal ideation or non-fatal suicide attempt,
even after adjustment for prior depression and substance
use disorders [4]. TUD may also be a risk factor for
suicide mortality [6–9]. Although prior research has
generally linked current tobacco use with an elevated
risk of suicide death, several studies have reported a non-
significant relationship [10–12]. The equivocal findings
may result, in part, from relatively small samples that
have been used to study the rare event of suicide. Conse-
quently, a recent meta-analysis pooled 15 cohort studies
to further clarify the potential association between
tobacco use and the risk of suicide mortality, and found
that the risk of death by suicide was 1.81 times greater
for current cigarette smokers compared with never
smokers [13].
Although meta-analyses are important to examine
the consistency of prior findings, they are constrained by
the limitations of available studies [14]. Importantly, the
studies comprising the Li et al. meta-analysis spanned
several decades (1973–2011), and a test of heterogeneity
revealed a smaller pooled relative risk estimate for current
smokers among studies published after 2000 than studies
published in or prior to 2000 [13]. In addition, the study
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number of observed suicide events ranged from34 to 601
[13]. Furthermore, prior studies vary in the extent to
which they have included adjustment for potentially
important confounding factors when estimating associa-
tions between current tobacco use and the risk of suicide
death. In particular, psychiatric conditions are correlated
with TUD [15,16], and are important risk factors for
suicide [17]. Of the 15 studies included in the meta-
analysis, only four adjusted for psychiatric illness or stress
[10,13,18–20]. Prior assessments of co-occurring psy-
chopathology have ranged from self-reported symptoms
of depression and stress to hospital diagnoses of psychi-
atric disorders. These limitations highlight the need for
further inquiry regarding the relationship between
current TUD and suicide mortality using more recent
data and larger samples, as well as including adjustment
for co-occurring psychopathology [17].
In this investigation, we assess the association
between current TUD and the risk of suicide death using
data from the largest integrated health system in the
United States, the Veterans Health Administration
(VHA). The study cohort includes all VHA users who
obtained care in the system within a single fiscal year
(FY), and we assess suicide mortality over the course of a
3-year follow-up interval. This approach ensures a large
sample size with sufficient power. In addition, the use of
VHA records enables assessment and adjustment for




We identified all VHA users who received VHA services in
FY 2005 and were alive at the beginning of FY 2006. A
FY begins on 1 October of the previous calendar year
and ends on 30 September of the calendar year (e.g. FY
2005 is 1 October 2004–30 September 2005). A total of
4 863 086 individuals met study inclusion criteria.
The study cohort was then assessed during the 3-year
follow-up interval, FYs 2006–2008, for the outcome
of suicide mortality. The VA Ann Arbor Institutional
Review Board approved project analyses.
Data sources
Data come from two sources: the VHA National Patient
Care Database (NPCD) and the Centers for Disease
Control and Prevention’s National Death Index (NDI).
The NPCD is a national VHA patient medical records
database that contains demographic information and
information on all VHA in-patient and out-patient
encounters, including diagnostic information associated
with all VHA clinical contacts [21,22]. Diagnoses in the
NPCD are based on clinical assessments and correspond
to the International Classification of Diseases, 9th revi-
sion, Clinical Modification (ICD-9-CM). The NDI includes
information on the date and cause of death for all
deaths that occur within the United States [23]. The NDI
records are based on death certificates that are filed in
state vital statistics offices. Within the NDI, causes of
death are classified according to the International
Classification of Diseases, 10th revision, Clinical Modifi-
cation (ICD-10-CM). The NDI is the most sensitive
population-based vital status data source in the United
States [24]. Using the method described by McCarthy
et al. [25] and Ilgen et al. [17,26], all individuals in the
study cohort were assessed for VHA service use in
FYs 2009 or 2010 (i.e. the two FYs directly following
the end of the 3-year study follow-up interval). Those
individuals with VHA service use in FYs 2009 or 2010
were assumed to be alive during the study follow-up
interval, and were not included in the NDI searches.
The NDI searches were then performed for all indivi-
duals in the cohort who had received VHA services in
FY 2005, were alive at the beginning of FY 2006 and
had no record of VHA service use in FYs 2009 or
2010. When multiple potential matches were identified




The outcome of interest in this study was suicide mortal-
ity during the 3-year follow-up interval, FYs 2006–2008.
Information on dates and causes of death were obtained
from NDI data. Suicide was identified using ICD-10-CM
codes X60-X84 and Y87.0.
Current TUD
The focal predictor of interest was current TUD in FYs
2004–2005, as assessed via NPCD records. TUD was
identified using the ICD-9-CM diagnostic code 305.1. The
diagnostic definition of TUD, as described in the ICD-9
volume I, Modified for US Purposes, is as follows: ‘Cases in
which tobacco is used to the detriment of a person’s
health or social functioning or in which there is tobacco
dependence [28]’. All TUD diagnoses were based on clini-
cal judgment and recorded by VHA health-care providers
during VHA encounters.
Other covariates
In the adjusted analyses we included other covariates,
most notably psychiatric conditions, thatmight confound
the relationship between TUD and the risk of suicide
death. The demographic characteristics of age group and
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sex were obtained from FY 2005 NPCD records. Charlson
comorbidity score, an established measure that classifies
comorbidity according to severity, was used to account
for medical comorbidities, and was based on clinical diag-
noses from FYs 2004–2005 NPCD records [29]. VHA
service connection, categorized as less than 50% or 50%
or greater, was obtained from FY 2005 NPCD records.
Psychiatric diagnoses of substance use disorder, bipolar
disorder, depression, other anxiety disorder, post-
traumatic stress disorder and schizophrenia were
obtained from the FYs 2004–2005 NPCD ICD-9-CM
diagnostic records.
Statistical analysis
All analyses were performed on the closed cohort of
4 863 086 individuals who used VHA services in FY
2005 and were alive at the start of FY 2006. Descriptive
analytical methods were used to examine characteristics
of the total cohort and by TUD status. Descriptive analy-
ses also calculated the number and percentage of deaths
by suicide during the 3-year follow-up interval among
the entire cohort, as well as among those with and
without diagnosed TUD. A series of proportional hazards
regression models were then used to estimate the asso-
ciation between current TUD and the risk of suicide
death, with analyses yielding hazard ratios (HRs) and
corresponding 95% confidence intervals (CIs) as the esti-
mates of association [30]. The first model estimated the
unadjusted, bivariate relationship between current TUD
and the risk of suicide death. The second model adjusted
for age group, sex, Charlson comorbidity score and
service connection. The third model was an elaboration
of the two previous models, with additional adjustment
for co-occurring psychiatric conditions (i.e. substance
use disorder, bipolar disorder, depression, other anxiety
disorder, post-traumatic stress disorder and schizophre-
nia). For the analyses, risk time for all individuals in the
cohort began on the first day of FY 2006 and ended on
the date of suicide or the last day of FY 2008, if alive at
that point. Individuals in the cohort who died due to
other causes during the follow-up interval were censored
at the date of their death. The proportional hazards
modeling procedures also took into account the clus-
tered nature of the data (i.e. with patients nested within
VHA facilities). All analyses were conducted using SAS
version 9.3.
RESULTS
Table 1 provides a description of the cohort, overall and
by TUD status. Of the 4 863 086 VHA users, 753 368
(15.5%) had a diagnosis of TUD in FYs 2004–2005. The
group with current TUD differed from the group without
current TUD on all the socio-demographic and health
characteristics presented in the table (P < 0.001). Among
patients withTUD there were greater percentages of indi-
viduals aged 40–49 years and 50–59 years compared
with those without TUD. In addition, there was a larger
percentage of males in the TUD group. There were
also greater percentages of individuals with medical
comorbidities (i.e. with a Charlson score of 1 or greater)
in the TUD group than in the group without TUD. A
greater percentage of those with TUD had VHA service
connection of 50% or greater compared with those
without TUD. With respect to co-occurring psychiatric
conditions, significantly greater percentages of each
psychiatric disorder were observed in the TUD group
compared with the group without TUD.
During the follow-up interval 4823 VHAusers died by
suicide, 1237 in the group with TUD and 3586 in the
group without TUD (also shown in Table 1). In addition,
493 030 individuals died from other causes during
follow-up, and were censored at the date of their death
(not shown in the Table). The mean length of follow-up
was 1040 days [standard deviation (SD) = 195.1] for the
entire cohort, 1038 days (SD = 197.7) for those with
TUD and 1040 days (SD = 194.7) for those without TUD
(Table 1). Themedian length of follow-up was 1096 days
(range = 1–1096) for the cohort, and did not differ by
TUD group.
Figure 1 displays the plots of the suicide-specific sur-
vivor function estimates for the two TUD groups. As
shown in the figure, the probability of survivorship was
greater for the group without TUD than the group with
TUD. During the entire 3-year follow-up interval, a larger
percentage of individuals with current TUD died by
suicide compared with those without current TUD (0.16
versus 0.09%, respectively; Table 2). Results from the
proportional hazards regression analyses estimating the
prospective association between currentTUD and the risk
of suicide mortality during follow-up are displayed in
Table 2. In the unadjusted, bivariate model, TUD was
associated significantly with an increased risk of suicide
(HR = 1.88; 95% CI = 1.76, 2.02). After adjustment for
age group, sex, Charlson comorbidity score and VHA
service connection, the HR estimate associated with TUD
was modestly attenuated, yet remained statistically sig-
nificant (HR = 1.79; 95% CI = 1.68, 1.91). The associa-
tion between TUD and the risk of suicide mortality was
further diminished in the third model, which adjusted for
age group, sex, Charlson score, service connection, sub-
stance use disorder, bipolar disorder, depression, other
anxiety disorder, post-traumatic stress disorder and
schizophrenia; none the less, the estimate remained
statistically significant (HR = 1.36; 95% CI = 1.27,
1.46). Furthermore, there was no evidence of violation of
the proportional hazards assumption. Namely, the two
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survivor curves do not intersect at any time during the
follow-up interval (as shown in Fig. 1), and the product
term between TUD and event time was not significant
(P = 0.8112) when it was included in the proportional
hazards regression analyses. Also of note, a parallel
approach using generalized estimating equations (GEE)
logistic regression to estimate the association between
TUD and the odds of suicide mortality during the entire
3-year follow-up yielded virtually identical results as the
proportional hazards models [i.e. model 1 odds ratio
(OR) = 1.88; 95% CI = 1.76, 2.01; model 2 OR = 1.76;
95%CI = 1.65, 1.88;model 3 OR = 1.34; 95%CI = 1.25,
1.44].
To understand more clearly the potential independent
influence of current TUD on suicide, we conducted a sen-
sitivity analysis among only those individuals in the
cohort without a diagnosed psychiatric disorder, i.e. sub-
stance use disorder, bipolar disorder, depression, other
anxiety disorder, post-traumatic stress disorder and
schizophrenia (n = 3 479 023). The sensitivity analysis
also included adjustment for age group, sex, Charlson
score and service connection. The resulting HR estimate
forTUDwas 1.47 (95%CI = 1.30, 1.65). Although some-
what larger, this finding was similar to the HR from the
third model in the main analysis.
DISCUSSION
The findings from the present investigation advance the
evidence base regarding the association between current
problematic tobacco use and the risk of suicide. In the
unadjusted analysis, individuals with current TUD had
an estimated 1.88 times greater risk of suicide death
during the follow-up interval compared with those
without current TUD. After the inclusion of important
covariates, the prospective association between current
TUD and the risk of suicide death was markedly attenu-
ated (i.e. HR = 1.36); however, the association remained
statistically significant.
To our knowledge, the present study is the single
largest examination of the potential impact of tobacco
use on the risk of death by suicide. The large sample
Table 1 Characteristics of the cohort of fiscal year (FY) 2005 Veterans Health Administration users who were alive at the beginning
of FY 2006, total and by tobacco use disorder (TUD) status (n = 4 863 086).
Characteristic
Total Tobacco use disorder (FY 2004/2005)
Yes No
n % n % n %
Total 4 863 086 100.0 753 368 100.0 4 109 718 100.0
Age group (years)
18–29 158 967 3.3 15 105 2.0 143 862 3.5
30–39 245 266 5.0 33 623 4.5 211 643 5.1
40–49 514 083 10.6 117 484 15.6 396 599 9.7
50–59 1 161 916 23.9 298 868 39.7 863 048 21.0
60–69 955 689 19.7 171 313 22.7 784 376 19.1
70–79 1 136 095 23.4 92 034 12.2 1 044 061 25.4
80+ 691 070 14.2 24 941 3.3 666 129 16.2
Male 4 460 447 91.7 712 147 94.5 3 748 300 91.2
Charlson score
Charlson score = 0 2 399 120 49.3 302 691 40.2 2 096 429 51.0
Charlson score = 1 1 130 024 23.2 211 855 28.1 918 169 22.3
Charlson score >1 1 333 942 27.4 238 822 31.7 1 095 120 26.6
Service connection ≥50% 618 753 12.7 121 759 16.2 496 994 12.1
Substance use disorder 420 954 8.7 206 078 27.4 214 876 5.2
Bipolar disorder 109 026 2.2 40 037 5.3 68 989 1.7
Depression 853 471 17.5 231 278 30.7 622 193 15.1
Other anxiety disorder 345 205 7.1 89 274 11.8 255 931 6.2
Post-traumatic stress disorder 359 060 7.4 104 657 13.9 254 403 6.2
Schizophrenia 107 412 2.2 40 939 5.4 66 473 1.6
No. of suicide deaths 4823 0.10 1237 0.16 3586 0.09
Mean length of follow-up in days (SD) 4 863 086 1040 (195.1) 753 368 1038 (197.7) 4 109 718 1040 (194.7)
Median length of follow-up in days
(range)
4 863 086 1096 (1–1096) 753 368 1096 (1–1096) 4 109 718 1096 (1–1096)
SD = standard deviation.
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size is a major strength of our investigation, and is par-
ticularly important when studying a rare outcome such
as suicide mortality. We evaluated the hypothesized asso-
ciation among a sample of more than 4.8 million indi-
viduals who used VHA services within a single year.
During the 3-year follow-up interval, there were 4823
observed suicide deaths. Our sample was approximately
three times larger than that of a recent meta-analysis
that pooled the findings of 15 prospective cohort studies
on the topic [13].
In the published meta-analysis, current smokers had
an 81% greater risk of suicide death than never smokers,
a finding comparable with the unadjusted TUD HR
estimate from this study [13]. The adjusted estimate from
the present investigation is similar to the pooled finding
among studies published after 2000 in the meta-analysis
[i.e. relative risk (RR) = 1.31] [10,12,13,18,19,31],
which differed significantly from the larger pooled find-
ing for studies published from 1973 through 2000
[6–9,11,13,20,32–35]. The comparable estimates from
the present study and more recent studies may reflect
the fact that more recent studies have tended to adjust
for other important factors of suicide, including co-
occurring psychopathology. Although prior research has
Figure 1 Suicide-specific survivor function estimates for the two tobacco use disorder (TUD) groups
Table 2 The association between tobacco use disorder (TUD) and risk of death by suicide from fiscal years (FYs) 2006–08 among
FY 2005 Veterans Health Administration (VHA) users who were alive at the beginning of FY 2006 (n = 4 863 086).
Suicide FYs
2006–2008 Model 1a Model 2b Model 3c
n % HR 95% CI P HR 95% CI P HR 95% CI P
Tobacco use disorder
Yes (n = 753 368) 1237 0.16 1.88 1.76 2.02 <0.0001 1.79 1.68 1.91 <0.0001 1.36 1.27 1.46 <0.0001
No (n = 4 109 718) 3586 0.09 Ref – – Ref – – Ref – –
CI = confidence interval; HR = hazard ratio. aModel 1 is unadjusted. bModel 2 is adjusted for age group, sex, Charlson score and VHA service connection.
cModel 3 is adjusted for age group, sex, Charlson score, VHA service connection, substance use disorder, bipolar disorder, depression, other anxiety
disorder, post-traumatic stress disorder and schizophrenia.
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documented relatively strong associations between psy-
chiatric disorders and the risk of subsequent suicide [17],
as well as the common co-occurrence of TUD and psychi-
atric illness [15,16], few prospective studies examining
tobacco use and suicide have considered the potential
confounding role of co-occurring psychiatric conditions.
Notably, the HR estimate for TUD from our adjusted
analysis is most consistent with the pooled RR estimate of
1.40 for current smokers among the four studies that
adjusted for mental illness in the published meta-analysis
[10,13,18–20].
Taken together, these results suggest that co-
occurring psychopathology may partially explain the
association between current TUD and the risk of suicide
death. Thus, appropriate treatment of comorbid psychi-
atric conditions may help to lower the risk of suicide
among individuals with current TUD and co-occurring
psychopathology. None the less, adjustment for co-
occurring psychiatric disorders did not completely dimin-
ish the association between TUD and suicide, suggesting
that current TUD may also be an important independent
risk factor for suicide death. Results from the sensitivity
analysis lend additional support for the potential
independent influence of current TUD on the risk of
suicide. Although further research is needed, clinicians’
assessment andmanagement of suicidal behavior among
patients with current TUD may be important for suicide
prevention.
Plausible theories linking current TUD and suicide
have been proposed and summarized previously in the
literature [3]. One possibility is that the association is
spurious, arising via correlation between TUD and
another factor (e.g. depression) that is associated with
suicide [3]. In our investigation, adjustment for other
important factors did not fully attenuate theTUDHR esti-
mate, which may indicate a true association between
current TUD and suicide. None the less, we cannot rule
out the possibility that an unmeasured, unadjusted factor
explains the observed association. Biological and psycho-
logical causal mechanisms have also been posited [3]. A
predominant theory in the literature emphasizes the role
of monamine oxidase (MAO). Namely, current tobacco
smoking is associated with lower levels of MAO [36,37],
which have also been found to be associated with psycho-
pathology and suicidality [3,38,39]. Others have theo-
rized that current tobacco use is related to suicide
through its influence on psychological factors, such as
mood and impulsivity [3,40]. Further research on these
and other potential causal mechanisms will be needed to
help clarify the association between current TUD and
suicide.
Although the present investigation provides impor-
tant information on the prospective link between current
TUD and the risk of suicide mortality, several potential
limitations should be considered. First, the study cohort
consisted of all FY 2005 VHA patients who were alive at
the beginning of FY 2006.Themajority of patients in the
VHA are older male Veterans; therefore, study findings
may not generalize to patient populations in other set-
tings. Previous epidemiological research has found that
older men are at greatest risk for suicide [41], and the
potential influence of TUD on suicide may differ in this
population subgroup compared with other subgroups. In
addition, McCarthy et al. found higher rates of suicide
among VHA patients compared with the general US
population [25]. Secondly, individuals with current TUD
were compared with individuals without current TUD in
the study analyses. We were unable to further categorize
those without TUD into separate former TUD and never
TUD groups. None the less, based on themajority of prior
studies that have not found a significant association,
former tobacco users and never tobacco users may be
equivalent with respect to subsequent suicide risk
[11,12,18]. Thirdly, althoughTUD is a marker of tobacco
use, it is not a directmeasure of tobacco exposure.Moreo-
ver, we do not have specific information on the frequency
and quantity of patients’ tobacco use, such as the
number of cigarettes smoked per day, which prevents the
examination of a potential dose–response association
between tobacco use and the risk of suicide. Fourthly,
TUD diagnoses, as well as other psychiatric diagnoses,
were derived from VHA administrative records and
are based on providers’ clinical assessment and judg-
ment. The validity and reliability of these diagnoses are
unknown. It is possible that incomplete ascertainment of
TUD and/or other psychiatric diagnoses may have influ-
enced the results. Fifthly, as TUD and psychiatric disor-
ders were assessed concurrently, sequence of onset could
not be determined.To the extent that there were individu-
als whose TUD caused their other psychiatric illness,
adjustment for psychiatric comorbidity would not be
appropriate [42]. Therefore, our adjusted results could be
interpreted as a conservative estimate of the effect of TUD
on the risk of suicide mortality. Moreover, to help clarify
the potential independent role of TUD on the risk of
suicide, we conducted a sensitivity analysis among those
individuals in the cohort without a diagnosed psychiatric
condition. Sixthly, it is possible that we did not adjust
adequately for all confounding factors in the final propor-
tional hazards model. For example, in a prior study, the
association between tobacco smoking and suicide was
explained by heavy alcohol use among tobacco smokers
[10]. Although we adjusted for the diagnosis of a sub-
stance use disorder, which includes alcohol use disorder,
inmodeling the association between currentTUD and the
risk of suicide mortality, inclusion of a measure of level
of alcohol use, were it available, rather than substance
use disorder may have resulted in a different TUD HR
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estimate. Similarly, future studies may wish to include
more detailed measures of socio-economic status when
modeling the association between TUD and the risk of
suicide mortality.
Despite these limitations, the present study suggests
that, independently, current TUD may confer a modest
excess risk of death by suicide. Consequently, TUDmay be
an important factor for health systems and clinicians to
incorporate into suicide risk assessment strategies. This
research also highlights the importance of considering
the potentially confounding influences of co-occurring
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